Nicholas Coleman+FollowFDA’s Fast Pass: New Drugs on the Express Lane?Heads up: The FDA just announced a new 'fast pass' for drug companies working on what they call 'national priorities.' Translation? If a medicine is seen as important for Americans, it could hit pharmacy shelves in just 1-2 months instead of the usual 10. This could mean quicker access to breakthrough treatments, but it also raises eyebrows—will speed come at the cost of safety? Keep an eye out for new meds popping up faster than your morning coffee brews! #FDA #HealthNews #DrugApproval #Business #Industry1813Share
Aaron Rodriguez+FollowBioNTech’s Big Cancer Drug MoveBioNTech is making waves again—this time, they’re prepping to file for approval of their first cancer drug, BNT323, by the end of 2024. But with all the tariff drama and global supply chain jitters, they’re not taking any chances: BioNTech’s diversifying its suppliers so they’re not just relying on China. Plus, they’re sitting on a massive cash pile from their COVID-19 vaccine days, fueling even more cancer research. New CFO incoming, too! #BioNTech #CancerResearch #PharmaNews #DrugApproval #Biotech #Health110Share
